William Plovanic
Stock Analyst at Canaccord Genuity
(0)
# 3229
Out of 5,270 analysts
151
Total ratings
39.44%
Success rate
1.83%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Tandem Diabetes Care | Maintains: Buy | 63 63 | 20.75 | 203.61% | 3 | Feb 26, 2025 | |
CeriBell | Maintains: Buy | 33 33 | 24.55 | 34.42% | 4 | Feb 26, 2025 | |
DexCom | Maintains: Strong Buy | 99 103 | 85.94 | 19.85% | 5 | Feb 14, 2025 | |
Edwards Lifesciences | Maintains: Hold | 68 71 | 71.41 | -0.57% | 15 | Feb 13, 2025 | |
AtriCure | Maintains: Strong Buy | 61 66 | 38.95 | 69.45% | 10 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 4 6 | 5.73 | 2.09% | 12 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 23 | 12.34 | 86.39% | 7 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 92 101 | 79.19 | 27.54% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 74 80 | n/a | n/a | 15 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 269 304 | 272.76 | 11.45% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 125 152 | 108.97 | 39.49% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 98 101 | 104.8 | -3.63% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 109 104 | 69.43 | 49.79% | 4 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 5.75 | 91.3% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 15 | 10.13 | 48.08% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 13 12 | 9.34 | 28.48% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 120 115 | 105.33 | 9.18% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 3 | 4.25 | -29.41% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 263 335 | n/a | n/a | 7 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 284 | 285.96 | -0.69% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 25 | 12.28 | 103.58% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 12 | 8.27 | 45.1% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 86 70 | 103.26 | -32.21% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 77 48 | 16.38 | 193.04% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 21 22 | 5.2 | 323.08% | 3 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 96 40 | n/a | n/a | 2 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 3 | 0.04 | 7400% | 5 | Jan 14, 2022 |